Postoperative changes in protein-induced vitamin K absence or antagonist II levels after hepatectomy in patients with hepatocellular carcinoma: Relationship to prognosis

HPB

Volumn 8, Issue 2, 2006, Pages 137-141

  Nanashima, A ^a   Sumida, Y ^a   Tobinaga, S ^a   Shibata, K ^a   Shindo, H ^a   Obatake, M ^a   Shibasaki, S ^a   Ide, N ^a   Nagayasu, Takeshi ^a  

^a NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

Author keywords

AFP; Hepatectomy; Hepatocellular carcinoma; PIVKA II

Indexed keywords

ALPHA FETOPROTEIN; DECARBOXYPROTHROMBIN;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CHEMOEMBOLIZATION; CONTROLLED STUDY; CORRELATION FUNCTION; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; POSTOPERATIVE PERIOD; PREDICTION; PREOPERATIVE PERIOD; PROGNOSIS; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 33646115434     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1080/13651820500273475     Document Type: Article

References (24)

1. Matsumoto, Y and Suzuki, T and Asada, I and Ozawa, K and Tobe, T and Honju, I. (1982) Clinical classification of hepatoma in Japan according to serial changes in serum alpha-fetoprotein levels Cancer, 49, pp. 354-60.
2. Williams, R and Melia, WM and Johnson, PJ. (1980) Serum alpha-foetoprotein in hepatocellular carcinoma - value in diagnosis, and prognosis Ann Acad Med Singapore, 9, pp. 245-50.
3. Peng, SY and Chen, WJ and Lai, PL and Jeng, YM and Sheu, JC and Hsu, HC. (2004) High alpha-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: Significance of hepatitis virus infection, age, p53 and beta-catenin mutations Int J Cancer, 112, pp. 44-50.
4. Yamanaka, J and Yamanaka, N and Nakasho, K and Tanaka, T and Ando, T and Yasui, C and et al. (2000) Hepatocellular carcinoma and liver transplantation. Clinicopathologic analysis of stage III-III hepatocellular carcinoma showing early massive recurrence after liver resection J Gastroenterol Hepatol., 15, pp. 1192-8.
5. Hu, KQ and Kyulo, NL and Lim, N and Elhazin, B and Hillebrand, DJ and Bock, T. (2004) Clinical significance of elevated alpha-fetoprotein (AFP) in patients with chronic hepatitis C, but not hepatocellular carcinoma Am J Gastroenterol., 99, pp. 860-5.
6. Nakagawa, T and Seki, T and Shiro, T and Wakabayashi, M and Imamura, M and Itoh, T and et al. (1999) Clinicopathologic significance of protein induced vitamin K absence or antagonist II and alpha-fetoprotein in hepatocellular carcinoma Int J Oncol., 14, pp. 281-6.
7. Okuda, H and Nakanishi, T and Takatsu, K and Saito, A and Hayashi, N and Yamamoto, M and et al. (2002) Clinicopathologic features of patients with hepatocellular carcinoma seropositive for alpha-fetoprotein-L3 and seronegative for des-gamma-carboxy prothrombin in comparison with those seropositive for des-gamma-carboxy prothrombin alone J Gastroenterol Hepatol., 17, pp. 772-8.
8. Inoue, S and Nakao, A and Harada, A and Nonami, T and Takagi, H. (1994) Clinical significance of abnormal prothrombin (DCP) in relation to postoperative survival and prognosis in patients with hepatocellular carcinoma Am J Gastroenterol., 89, pp. 2222-6.
9. Suehiro, T and Sugimachi, K and Matsumata, T and Itasaka, H and Taketomi, A and Maeda, T. (1994) Protein induced by vitamin K absence or antagonist II as a prognostic marker in hepatocellular carcinoma. Comparison with alpha-fetoprotein Cancer, 73, pp. 2464-71.
10. Nakagawa, T and Seki, T and Shiro, T and Wakabayashi, M and Imamura, M and Itoh, T and et al. (1999) Clinicopathologic significance of protein induced vitamin K absence or antagonist II and alpha-fetoprotein in hepatocellular carcinoma Int J Oncol., 14, pp. 281-6.
11. Tamano, M and Sugaya, H and Oguma, M and Iijima, M and Yoneda, M and Murohisa, T and et al. (2002) Serum and tissue PIVKA-II expression reflect the biological malignant potential of small hepatocellular carcinoma Hepatol Res., 22, pp. 261-9.
12. Liver Cancer Study Group of Japan. Stage. In: The general rules for the clinical and pathological study of primary liver cancer, 4th edn. Tokyo: Kanehara & Co., 2000:19(in Japanese).
13. The Brisbane 2000 Terminology of Liver Anatomy and Resections. HPB 2000;2:333-9.
14. Yamashita, F and Tanaka, M and Satomura, S and Tanikawa, K. (1996) Prognostic significance of Lens culinaris agglutinin A-reactive alpha-fetoprotein in small hepatocellular carcinomas Gastro-enterology, 111, pp. 996-1001.
15. Yamashiki, N and Seki, T and Wakabayashi, M and Nakagawa, T and Imamura, M and Tamai, T and et al. (1999) Usefulness of Lens culinaris agglutinin A-reactive fraction of alpha-fetoprotein (AFP-L3) as a marker of distant metastasis from hepatocellular carcinoma Oncol Rep., 6, pp. 1229-32.
16. Yamashita, F and Tanaka, M and Satomura, S and Tanikawa, K. (1995) Monitoring of lectin-reactive alpha-fetoproteins in patients with hepatocellular carcinoma treated using transcatheter arterial embolization Eur J Gastroenterol Hepatol., 7, pp. 627-33.
17. Khan, KN and Yatsuhashi, H and Yamasaki, K and Yamasaki, M and Inoue, O and Koga, M and et al. (2000) Prospective analysis of risk factors for early intrahepatic recurrence of hepatocellular carcinoma following ethanol injection J Hepatol., 32, pp. 269-78.
18. Okuda, K and Ohtsuki, T and Obata, H and Tomimatsu, M and Okazaki, N and Hasegawa, H and et al. (1985) Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients Cancer, 56, pp. 918-28.
19. Adachi, E and Maeda, T and Matsumata, T and Shirabe, K and Kinukawa, N and Sugimachi, K and et al. (1995) Risk factors for intrahepatic recurrence in human small hepatocellular carcinoma Gastroenterology, 108, pp. 768-75.
20. Ko, S and Nakajima, Y and Kanehiro, H and Hisanaga, M and Aomatsu, Y and Kin, T and et al. (1996) Significant influence of accompanying chronic hepatitis status on recurrence of hepatocellular carcinoma after hepatectomy. Result of multivariate analysis Ann Surg, 224, pp. 591-5.
21. Nanashima, A and Morino, S and Yamaguchi, H and Tanaka, K and Shibasaki, S and Tsuji, T and et al. (2003) Modified CLIP using PIVKA-II for evaluating prognosis after hepatectomy for hepatocellular carcinoma Eur J Surg Oncol., 29, pp. 735-42.
22. Nakao, A and Taniguchi, K and Inoue, S and Harada, A and Nonami, T and Watanabe, K and et al. (1996) Usefulness of simultaneous determination of alpha-fetoprotein and des-gamma-carboxy prothrombin in hepatocellular carcinoma Semin Surg Oncol., 12, pp. 160-3.
23. Koh, T and Taniguchi, H and Katoh, H and Kunishima, S and Yamaguchi, A and Yamagishi, H. (2002) Are both PIVKA-II and alpha-fetoprotein necessary in follow-up management after hepatic resection for hepatocellular carcinoma? Hepatogastroenterology, 49, pp. 1615-18.
24. Kanazumi, N and Takeda, S and Inoue, S and Ohshima, K and Sugimoto, H and Kaneka, T and et al. (2000) PIVKA-II during perioperative period in patients with hepato-biliary-pancreatic diseases Hepatogastroenterology, 47, pp. 1695-9.